Sudden Infant Death Syndrome: Review of implicated genetic factors

American Journal of Medical Genetics, Part A

Volumn 143, Issue 8, 2007, Pages 771-788

  Weese Mayer, Debra E ^a,e,f   Ackerman, Michael J ^b   Marazita, Mary L ^c,d   Berry Kravis, Elizabeth M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Mayo Clinic   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e RUSH MEDICAL COLLEGE   (United States)

^f Rush Children's Hospital and Rush University Medical Center   (United States)

Author keywords

ANS genes; Channelopathy genes; Serotonin genes; SIDS

Indexed keywords

ION CHANNEL;

AUTONOMIC NEUROPATHY; CIGARETTE SMOKING; ENERGY YIELD; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC REGULATION; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOGLYCEMIA; INFLAMMATION; LOW BIRTH WEIGHT; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK FACTOR; SUDDEN INFANT DEATH SYNDROME; THERMOREGULATION;

FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LONG QT SYNDROME; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUDDEN INFANT DEATH;

EID: 34147129252     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31722     Document Type: Review

References (156)

1. Ackerman MJ. 2004. Cardiac channelopathies: It's in the genes. Nat Med 10:463-464.
2. Ackerman MJ, Tester DJ, Porter CJ. 1999. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clinic Proc 74:1088-1094.
3. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towhin JA. 2001. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286:2264-2269.
4. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. 2003. Ethnic differences in cardiac potassium channel variants: Implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clinic Proc 78:1479-1487.
5. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, Keating MT, Jones G, Chadha M, Burrow CR, Stephens JC, Xu C, Judson R, Curran ME. 2004. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: Implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1:600-607.
6. Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneau M, Vekemans M, Munnich A, Gaultier C, Lyonnet S. 2003. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459-461.
7. Anderson HR, Cook DG. 1997. Passive smoking and sudden infant death syndrome: Review of the epidemiological evidence. Thorax 52:1003-1009.
8. Arnestad M, Andersen M, Vege A, Rognum TO. 2001. Changes in the epidemiological pattern of sudden infant death syndrome in southeast Norway. 1984-1998: Implications for future prevention and research. Arch Dis Child 85:108-115.
9. Arnestad M, Opdal SH, Musse MA, Vege A, Rognum TO. 2002. Are substitutions in the first hypervariable region of the mitochondrial DNA displacement-loop in sudden infant death syndrome due to maternal inheritance? Acta Paediatr 91:1060-1064.
10. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL Jr, Schwartz PJ. 2007. Prevalence of long QT syndrome gene variants in sudden infant death syndrome. Circulation (in press).
11. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. 2000. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3-28.
12. Battersby S, Ogilvie AD, Blackwood DH, Shen S, Muqit MM, Muir WJ, Teague P, Goodwill GM, Harmar AJ. 1999. Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter gene. J Neurochem 72:1384-1388.
13. Berry-Kravis EM, Zhou L, Rand CM, Weese-Mayer DE. 2006. Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. Am J Respir Crit Care Med 174:1139-1144.
14. Blackwell CC, Moscovis SM, Gordon AE, Al Madani OM, Hall ST, Gleeson M, Scott RJ, Roberts-Thomson J, Weir DM, Busuttil A. 2005. Cytokine responses and sudden infant death syndrome: Genetic, developmental, and environmental risk factors. J Leukoc Biol 78:1242-1254.
15. Blair PS, Fleming PJ, Bensley D, Smith I, Bacon C, Taylor E, Berry J, Golding J, Tripp J. 1996. Smoking and the sudden infant death syndrome: Results from 1993-5case-control study for confidential inquiry into stillbirths and deaths in infancy. Confidential Enquiry into Stillbirths and Deaths Regional Coordinators and Researchers. BMJ 313:195-198.
16. Brooke H, Gibson A, Tappin D, Brown H. 1997. Case-control study of sudden infant death syndrome in Scotland, 1992-5. BMJ 314:1516-1520.
17. Bruning G, Liangos O, Baumgarten HG. 1997. Prenatal development of the serotonin transporter in mouse brain. Cell Tissue Res 289:211-221.
18. Burchell A, Lyall H, Busuttil A, Bell E, Hume R. 1992. Glucose metabolism and hypoglycaemia in SIDS. J Clin Pathol 45:39-45.
19. Burchell A, Forsyth L, Hume R. 2002. Polymorphisms in genes involved in glucose metabolism in cases of sudden infant death syndrome. Child Care Health Dev 28:37-39.
20. Burton MD, Kawashima A, Brayer JA, Kazemi H, Shannon DC, Schuchardt A, Costantini F, Pachnis V, Kinane TB. 1997. RET proto-oncogene is important for the development of respiratory CO2 sensitivity. J Auton Nerv Syst 63:137-143.
21. Christiansen M, Tonder N, Larsen LA, Andersen PS, Simonsen H, Oyen N, Kanters JK, Jacobsen JR, Fosdal I, Wettrell G, Kjeldsen K. 2005. Mutations in the HERG K+-ion channel: A novel link between long QT syndrome and sudden infant death syndrome. [see comment]. Am J Cardiol 95:433-434.
22. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts GW, Smith G, Morton J, Murray RM, Smith D, Kirov G. 1996a. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 7:1075-1679.
23. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP. 1996b. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. [see comment]. Mol Psychiatry 1:453-460.
24. Crawley BA, Morris JA, Drucker DB, Barson AJ, Morris J, Knox WF, Oppenheim BA. 1999. Endotoxin in blood and tissue in the sudden infant death syndrome. FEMS Immunol Med Microbiol 25:131-135.
25. Cronk LB, Ye B, Kaku T, Tester DJ, Vatta M, Makielski JC, Ackerman MJ. 2007. Novel mechanism for Sudden Infant Death Syndrome (SIDS): Persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 4:l6l-166.
26. Crotti L, Arnestad M, Insolia R, Pedrazzini M, Ferrandi C, Rognum T, Schwartz PJ. 2005. The role of long QT syndrome in Sudden Infant Death Syndrome. Eur Heart J 26(Abstr Suppl):127.
27. Curran S, Purcell S, Craig I, Asherson P, Sham P. 2005. The serotonin transporter gene as a QTL for ADHD. Am J Med Genet Part B Neuropsychiatr Genet 134B:42-47.
28. Divne AM, Rasten-Almqvist P, Rajs J, Gyllensten U, Alien M. 2003. Analysis of the mitochondrial genome in sudden infant death syndrome. Acta Paediatr 92:386-388.
29. Du L, Bakish D, Hrdina PD. 2000. Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet 10:159-164.
30. Fatemi A, Item C, Stockler-Ipsiroglu S, Ipsiroglu O, Sperl W, Patsch W, Strobl W. 2002. Sudden infant death: No evidence for linkage to common polymorphisms in the uncoupling protein-1 and the beta3-adrenergic receptor genes. Eur J Pediatr 161:337-339.
31. Filiano JJ, Kinney HC. 1994. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: The triple-risk model. Biol Neonate 65:194-197.
32. Fiskerstrand CE, Lovejoy EA, Quinn JP. 1999. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 458:171-174.
33. Fleming PJ, Gilbert R, Azaz Y, Berry PJ, Rudd PT, Stewart A, Hall E. 1990. Interaction between bedding and sleeping position in the sudden infant death syndrome: A population based case-control study. BMJ 301:85-89.
34. Forsyth L, Hume R, Howatson A, Busuttil A, Burchell A. 2005. Identification of novel polymorphisms in the glucokinase and glucose-6-phosphatase genes in infants who died suddenly and unexpectedly. J Mol Med 83:610-618.
35. Franco P. Szliwowski H, Dramaix M, Kahn A. 1999. Decreased autonomic responses to obstructive sleep events in future victims of sudden infant death syndrome. Pediatr Res 46:33-39.
36. Franco P, Chabanski S, Szliwowski H, Dramaix M, Kahn A. 2000. Influence of maternal smoking on autonomic nervous system in healthy infants. Pediatr Res 47:215-220.
37. McElvaneyGallagher PM, Lowe G, Fitzgerald T, Bella A, Greene CM, McElvaney NG, O'Neill SJ. 2003. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58:154-156.
38. Garcia-Barcelo M, Sham MH, Lui VC, Chen BL, Ott J, Tam PK. 2003. Association study of PHOX2B as a candidate gene for Hirschsprung's disease. Gut 52:503-507.
39. Gelernter J, Kranzler H, Coccaro EF, Siever LJ, New AS. 1998. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry 155:1332-1338.
40. Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK. 1999. Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 88:61-66.
41. Gocze PM, Szabo I, Freeman DA. 1999. Influence of nicotine, cotinine, anabasine and cigarette smoke extract on human granulosa cell progesterone and estradiol synthesis. Gynecol Endocrinol 13 266-272.
42. Goldwater PN. 2004. SIDS pathogenesis: Pathological findings indicate infection and inflammatory responses are involved. FEMS Immunol Med Microbiol 42:11-20.
43. Goulene KS-BM, Crotti L, Priori SG, Salice P, Mannarino S, Rosati E, Schwartz PJ. 2005. Neonatal electrocardiographic screening of genetic arrhythmogenic disorders and congenital cardiovascular diseases: Prospective data from 31,000 infants. Eur Heart J 26:214.
44. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. 2002. Serotonin transporter genetic variation and the response of the hitman amygdala. Science 297:400-403.
45. Hayashi S, Watanabe J, Kawajiri K. 1992. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866-870.
46. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. 1996. Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624.
47. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR. 2000. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47:643-649.
48. Helminen ME, Kilpinen S, Virta M, Hurme M. 2001. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 184:777-780.
49. Himmelberger DU, Brown BW Jr, Cohen EN. 1978. Cigarette smoking during pregnancy and the occurrence of spontaneous abortion and congenital abnormality. Am J Epidemiol 108:470-479.
50. Hirsch MR, Tiveron MC, Guillemot F, Brunei JF, Goridis C. 1998. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development 125:599-608.
51. Hoyert DL, Heron MP, Murphy SL, Kung HC. 2006. Deaths: Final data for 2003. Natl Vital Stat Rep 54:1-120.
52. Hu S, Brody CL, Fisher C, Gunzerath L, Nelson ML, Sabol SZ, Sirota LA, Marcus SE, Greenberg BD, Murphy DL, Hamer DH. 2000. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry 5:181-188.
53. Hunt CE. 2005. Gene-environment interactions: Implications for sudden unexpected deaths in infancy. Arch Dis Child 90:48-53.
54. Hunt CE, Hauck FR. 2006. Sudden infant death syndrome. CMAJ 174:1861-1869.
55. Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, Kelsey KT. 1997. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. Cancer Epidemiol Biomarkers Prev 6:1075-1080.
56. Ishiguro H, Saito T, Akazawa S, Mitushio H, Tada K, Enomoto M, Mifune H, Toru M, Shibuya H, Arinami T. 1999. Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population. Alcohol Clin Exp Res 23:1281-1284.
57. Jacobs BL, Azmitia EC. 1992. Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
58. Kaada B, Spurkland A. 1992. No association between HLA-DR2 and the sudden infant death syndrome. Acta Paediatr 81:283.
59. Kahn A, Groswasser J, Rebuffat E, Sottiaux M, Blum D, Foerster M, Franco P, Bochner A, Alexander M, Bachy A, Richard P, Verghote M, Le Polain D, Wayenberg JL. 1992. Sleep and cardiorespiratory characteristics of infant victims of sudden death: A prospective case-control study. Sleep 15:287-292.
60. Katsuragi S, Kunugi H, Sano A, Tsutsumi T, Isogawa K, Nanko S, Akiyoshi J. 1999. Association between serotonin transporter gene polymorphism and anxiety-related traits. Biol Psychiatry 45:368-370.
61. Keller E, Andreas A, Teifel-Greding J, Baur C, Josephi E, Beer G, Albert ED, Liebhardt E. 1990. DNA analysis of HLA class II and III genes in sudden infant death (SIDS). Beitr Gerichtl Med 48:285-290.
62. Kijima K, Sasaki A, Niki T, Umetsu K, Osawa M, Matoba R, Hayasaka K. 2004. Sudden infant death syndrome is not associated with the mutation of PHOX2B gene, a major causative gene of congenital central hypoventilation syndrome. Tohoku J Exp Med 203:65-68.
63. Kinney HC, Randall LL, Sleeper LA, Willinger M, Belliveau RA, Zec N, Rava LA, Dominici L, Iyasu S, Randall B, Habbe D, Wilson H, Mandel F, McClain, Welty TK. 2003. Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome. J Neuropathol Exp Neurol 62:1178-1191.
64. Kline J, Stein ZA, Susser M, Warburton D. 1977. Smoking: A risk factor for spontaneous abortion. N Engl J Med 297:793-796.
65. Kochanek KD, Hudson BL. 1995. Advance Report of Final Mortality Statistics 1992. Hyattsville, MD: National Center for Health Statistics.
66. Kotamaki M. 1995. Smoking induced differences in autonomic responses in military pilot candidates. Clin Auton Res 5:31-36.
67. Law SK, Dodds AW, Porter RR. 1984. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J 3:1819-1823.
68. Ledwidge M, Fox G, Matthews T. 1998. Neurocardiogenic syncope: A model for SIDS. Arch Dis Child 78:481-483.
69. Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR, Caporaso N. 1998. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev 7:253-255.
70. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P. 1994. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 95:157-162.
71. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. [see comment]. Science 274:1527-1531.
72. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH. 1998. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213.
73. Lo L, Tiveron MC, Anderson DJ. 1998. MASH1 activates expression of the paired homeodomain transcription factor Phox2a, and couples pan-neuronal and subtype-specific components of autonomic neuronal identity. Development 125:609-620.
74. Lo L, Morin X, Brunei JF, Anderson DJ. 1999. Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells. Neuron 22:693-705.
75. Lovejoy EA, Scott AC, Fiskerstrand CE, Bubb VJ, Quinn JP. 2003. The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit. Eur J Neurosci 17:417-420.
76. Lucini D, Bertocchi F, Malliani A, Pagani M. 1996. A controlled study of the autonomic changes produced by habitual cigarette smoking in healthy subjects. Cardiovasc Res 31:633-639.
77. MacDorman MF, Cnattingius S, Hoffman HJ, Kramer MS, Haglund B. 1997. Sudden infant death syndrome and smoking in the United States and Sweden. Am J Epidemiol 146:249-257.
78. MacKenzie A, Quinn J. 1999. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 96:15251-15255.
79. Maher BS, Marazita ML, Rand C, Zhou L, Berry-Kravis EM, Weese-Mayer DE. 2006. 3′ UTR polymorphism of the serotonin transporter gene and sudden infant death syndrome: Haplo-type analysis. Am J Med Genet Part A 140A:1453-1457.
80. Marazita ML, Maher BS, Cooper ME, Silvestri JM, Huffman AD, Smok-Pearsall SM, Kowal MH, Weese-Mayer DE. 2001. Genetic segregation analysis of autonomic nervous system dysfunction in families of probands with idiopathic congenital central hypoventilation syndrome. Am J Med Genet 100:229-236.
81. Maron BJ, Clark CE, Goldstein RE, Epstein SE. 1976. Potential role of QT interval prolongation in sudden infant death syndrome. Circulation 54:423-430.
82. Matera I, Bachetti T, Puppo F, Di Duca M, Morandi F, Casiraghi GM, Cilio MR, Hennekam R, Hofstra R, Schober JG, Ravazzolo R, Ottonello G, Ceccherini I. 2004. PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset central hypoventilation syndrome. J Med Genet 41:373-380.
83. Melke J, Westberg L, Landen M, Sundblad C, Eriksson O, Baghei F, Rosmond R, Eriksson E, Ekman A. 2003. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinology 28:446-458.
84. Meny RG, Carroll JL, Carbone MT, Kelly DH. 1994. Cardiorespiratory recordings from infants dying suddenly and unexpectedly at home. Pediatrics 93:44-49.
85. Mitchell EA, Tuohy PG, Brunt JM, Thompson JM, Clements MS, Stewart AW, Ford RP, Taylor BJ. 1997. Risk factors for sudden infant death syndrome following the prevention campaign in New Zealand: A prospective study. Pediatrics 100:835-840.
86. Moiseiwitsch JR, Lauder JM. 1995. Serotonin regulates mouse cranial neural crest migration. Proceedings of the National Academy of Sciences of the United States of America 92:7182-7186.
87. Morris JA, Harrison LM, Partridge SM. 2006. Postmortem bacteriology: A re-evaluation. J Clin Pathol 59:1-9.
88. Moscovis SM, Gordon AE, Hall ST, Gleeson M, Scott RJ, Roberts-Thomsom J, Weir DM, Busuttil A, Blackwell CC. 2004. Interleukin 1-beta responses to bacterial toxins and sudden infant death syndrome. FEMS Immunol Med Microbiol 42:139-145.
89. Moss AJ, Robinson JL, Gessman L, Gillespie R, Zareba W, Schwartz PJ, Vincent GM, Benhorin J, Heilbron EL, Towbin JA, Priori SG, Napolitano C, Zhang L, Medina A, Andrews ML, Timothy K. 1999. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 84:876-879.
90. Naeye RL, Harkness WL, Utts J. 1977. Abruptio placentae and perinatal death: A prospective study. Am J Obstet Gynecol 128:740-746.
91. Nakachi K, Imai K, Hayashi S, Kawajiri K. 1993. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53:2994-2999.
92. Nakamura T, Muramatsu T, Ono Y, Matsushita S, Higuchi S, Mizushima H, Yoshimura K, Kanba S, Asai M. 1997. Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. Am J Med Genet 74:544-545.
93. Narita N, Narita M, Takashima S, Nakayama M, Nagai T, Okado N. 2001. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics 107:690-692.
94. Niedermaier ON, Smith ML, Beightol LA, Zukowska-Grojec Z, Goldstein DS, Eckberg DL. 1993. Influence of cigarette smoking on human autonomic function. Circulation 88:562-571.
95. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM. Smith CA. 1996. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347:731-733.
96. O'Neill GJ, Yang SY, Dupont B. 1978. Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci USA 75:5165-5169.
97. Opdal SH, Rognum TO. 2004. The sudden infant death syndrome gene: Does it exist? Pediatrics 114:e506-e512.
98. Opdal SH, Vege A, Saugstad OD, Rognum TO. 1994. Is partial deletion of the complement C4 genes associated with sudden infant death? Eur J Pediatr 153:287-290.
99. Opdal SH, Rognum TO, Vege A, Stave AK, Dupuy BM, Egeland T. 1998. Increased number of substitutions in the D-loop of mitochondrial DNA in the sudden infant death syndrome. Acta Paediatr 87:1039-1044.
100. Opdal SH, Rognum TO, Torgersen H, Vege A. 1999a. Mitochondrial DNA point mutations detected in four cases of sudden infant death syndrome. Acta Paediatr 88:957-960.
101. Opdal SH, Vege A, Stave AK, Rognum TO. 1999b. The complement component C4 in sudden infant death. Eur J Pediatr 158:210-212.
102. Opdal SH, Vege A, Egeland T, Musse MA, Rognum TO. 2002. Possible role of mtDNA mutations in sudden infant death. Pediatr Neurol 27:23-29.
103. Opdal SH, Opstad A, Vege A, Rognum TO. 2003. IL-10 gene polymorphisms are associated with infectious cause of sudden infant death. Hum Immunol 64:1183-1189.
104. Osher Y, Hamer D, Benjamin J. 2000. Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs. Mol Psychiatry 5:216-219.
105. Ozawa Y. Okado N. 2002. Alteration of serotonergic receptors in the brainstems of human patients with respiratory disorders. Neuropediatrics 33:142-149.
106. Panigrahy A, Filiano J, Sleeper LA, Mandell F, Valdes-Dapena M, Krous HF, Rava LA, Foley E, White WF, Kinney HC. 2000. Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome. J Neuropathol Exp Neurol 59:377-384.
107. Paterson DS, Trachtenbert FL, Thompson EG, Belliveau RA, Beggs AH, Darnall RA, Chadwick AE, Krous HF, Kinney HC. 2006. Multiple serotonergic brainstem abnormalities in the Sudden Infant Death Syndrome. JAMA 296:2124-2132.
108. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF. 1997. Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development 124:4065-4075.
109. Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF. 1999. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366-370.
110. Pattyn A, Vallstedt A, Dias JM, Samad OA, Krumlauf R, Rijli FM, Brunet J-F, Ericson J. 2003. Coordinated temporal and spatial control of motor neuron and serotonergic neuron generation from a common pool of CNS progenitors. Genes Dev 17:729-737.
111. Pattyn A, Simplicio N, van Doorninck JH, Goridis C, Guillemot F, Brunet JF. 2004. Ascl1/Mash1 is required for the development of central serotonergic neurons. Nat Neurosci 7:589-595.
112. Piha SJ. 1994. Cardiovascular autonomic reflexes in heavy smokers. J Auton Nerv Syst 48:73-77.
113. Plant LD, Bowers PN, Liu Q, Morgan T, Zhang T, State MW, Chen W, Kittles RA, Goldstein SA. 2006. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 116:430-435.
114. Pollack H, Lantz PM, Frohna JG. 2000. Maternal smoking and adverse birth outcomes among singletons and twins. Am J Public Health 90:395-400.
115. Ponsonby AL. Dwyer T, Gibbons LE, Cochrane JA, Jones ME, McCall MJ. 1992. Thermal environment and sudden infant death syndrome: Case-control study. BMJ 304:277-282.
116. Pope CA, III, Eatough DJ, Gold DR, Pang Y, Nielsen KR, Nath P, Verrier RL, Kanner RE. 2001. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect 109:711-716.
117. Quaglini S, Rognoni C, Spazzolini C, Priori SG, Mannarino S, Schwartz PJ. 2006. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J 27:1824-1832.
118. Rahim RA, Boyd PA, Ainslie Patrick WJ, Burdon RH. 1996. Human heat shock protein gene polymorphisms and sudden infant death syndrome. Arch Dis Child 75:451-452.
119. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD. 1993. Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
120. Rand CM, Weese-Mayer DE, Maher BS, Cooper ME, Marazita ML, Berry-Kravis EM. 2006a. Sudden infant death syndrome: Case-control frequency differences in paired like homeobox (PHOX) 2B gene. Am J Med Genet Part A 140A:1687-1691.
121. Rand CM, Weese-Mayer DE, Maher BS, Zhou L, Marazita ML, Berry-Kravis EM. 2006b. Nicotine metabolizing genes GSTT1 and CYP1A1 in sudden infant death syndrome. Am J Med Genet Part A 140A:1447-1452.
122. Raymond EG, Mills JL. 1993. Placental abruption. Maternal risk factors and associated fetal conditions. Acta Obstet Gynecol Scand 72:633-639.
123. Raymond EG, Cnattingius S, Kiely JL. 1994. Effects of maternal age, parity, and smoking on the risk of stillbirth. Br J Obstet Gynaecol 101:301-306.
124. Renolleau S, Dauger S, Vardon G, Levacher B, Simonneau M, Yanagisawa M, Gaultier C, Gallego J. 2001. Impaired ventilatory responses to hypoxia in mice deficient in endothelin-converting-enzyme-1. Pediatr Res 49:705-712.
125. Santorelli FM, Schlessel JS, Slonim AE, DiMauro S. 1996. Novel mutation in the mitochondrial DNA tRNA glycine gene associated with sudden unexpected death. Pediatr Neurol 15:145-149.
126. Sasaki A, Kanai M, Kijima K, Akaba K, Hashimoto M, Hasegawa H, Otaki S, Koizumi T, Kusuda S, Ogawa Y, Tuchiya K, Yamamoto W, Nakamura T, Hayasaka K. 2003. Molecular analysis of congenital central hypoventilation syndrome. Hum Genet 114:22-26.
127. Schechtman VL, Harper RM, Kluge KA, Wilson AJ, Hoffman HJ, Southall DP. 1988. Cardiac and respiratory patterns in normal infants and victims of the sudden infant death syndrome. Sleep 11:413-424.
128. Schneider PM, Wendler C, Riepert T, Braun L, Schacker U, Horn M, Althoff H, Mattern R, Rittner C. 1989. Possible association of sudden infant death with partial complement C4 deficiency revealed by post-mortem DNA typing of HLA class II and III genes. Eur J Pediatr 149:170-174.
129. Schwartz PJ. 1976. Cardiac sympathetic innervation and the sudden infant death syndrome. A possible pathogenetic link. Am J Med 60:167-172.
130. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, Grancini F, Marni ED, Perticone F, Rosti D, Salice P. 1998. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 338:1709-1714.
131. Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-Badiale M, Richard TA, Berti MR, Bloise R. 2000. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 343:262-267.
132. Schwartz PJ, Priori SG, Bloise R, Napolitano C, Ronchetti E, Piccinini A, Goj C, Breithardt G, Schulze-Bahr E, Wedekind H, Nastoli J. 2001a. Molecular diagnosis in a child with sudden infant death syndrome. Lancet 358:1342-1343.
133. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. 2001b. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95.
134. Schwartz-Bickenbach D, Schulte-Hobein B, Abt S, Plum C, Nau H. 1987. Smoking and passive smoking during pregnancy and early infancy: Effects on birth weight, lactation period, and cotinine concentrations in mother's milk and infant's urine. Toxicol Lett 35:73-81.
135. Shiono PH, Klebanoff MA, Rhoads GG. 1986. Smoking and drinking during pregnancy. Their effects on preterm birth. JAMA 255:82-84.
136. Shiono PH, Klebanoff MA, Nugent RP, Cotch MF, Wilkins DG, Rollins DE, Carey JC, Behrman RE. 1995. The impact of cocaine and marijuana use on low birth weight and preterm birth: A multicenter study. Am J Obstet Gynecol 172(1 Pt 1):19-27.
137. Shirasawa S, Arata A, Onimaru H, Roth KA, Brown GA, Horning S, Arata S, Okumura K, Sasazuki T, Korsmeyer SJ. 2000. Rnx deficiency results in congenital central hypoventilation. Nat Genet 24:287-290.
138. Summers AM, Summers CW, Drucker DB, Hajeer AH, Barson A, Hutchinson IV. 2000. Association of IL-10 genotype with sudden infant death syndrome. Hum Immunol 61:1270-1273.
139. Sun Z, Milos PM, Thompson JF, Lloyd DB, Mank-Seymour A, Richmond J, Cordes JS, Zhou J. 2004. Role of a KCNH2 polymorphism (R1047 L) in dofetilide-induced Torsades de Pointes. J Mol Cell Cardiol 37:1031-1039.
140. Taylor BJ, Williams SM, Mitchell EA, Ford RP. 1996. Symptoms, sweating and reactivity of infants who die of SIDS compared with community controls. New Zealand National Cot Death Study Group. J Paediatr Child Health 32:316-322.
141. Tester DJ, Ackerman MJ. 2005. Sudden infant death syndrome: How significant are the cardiac channelopathies? Cardiovasc Res 67:388-396.
142. Tester DJ, Dura M, Carturan E, Reiken S, Wronska A, Marks AR, Ackerman MJ. 2007. A mechanism for Sudden Infant Death Syndrome (SIDS): Stress-induced leak via ryanodine receptors. Heart Rhythm (in press).
143. Trochet D, O'Brien LM, Gozal D, Trang H, Nordenskjold A, Laudier B, Svensson PJ, Uhrig S, Cole T, Niemann S, Munnich A, Gaultier C, Lyonnet L, Amiel J. 2005. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am J Hum Genet 76:421-426.
144. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, Kamp TJ, Towbin JA. 2006. Mutant Caveolin-3 induces persistent late sodium current and is associated with Long QT Syndrome. Circulation 114:2104-2112.
145. Vege A, Rognum T. 2004. Sudden infant death syndrome, infection and inflammatory responses. FEMS Immunol Med Microbiol 42:3-10.
146. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X. 2002. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287:195-202.
147. Wang DW, Desai RR, Crotti L, Arnestad M, Insolia R, Pedrazzini M. Ferrandi C, Vege A, Rognum T, Schwartz PJ, George AL Jr. 2007. Cardiac sodium channel dysfunction in Sudden Infant Death Syndrome. Circulation 115:368-376.
148. Weese-Mayer DE, Silvestri JM, Marazita ML, Hoo JJ. 1993. Congenital central hypoventilation syndrome: Inheritance and relation to sudden infant death syndrome. Am J Med Genet 47:360-367.
149. Weese-Mayer DE, Shannon DC, Keens TG, Silvestri JM. 1999. Idiopathic congenital central hypoventilation syndrome: Diagnosis and management. American Thoracic Society. Am J Respir Crit Care Med 160:368-373.
150. Weese-Mayer DE, Silvestri JM, Huffman AD, Smok-Pearsall SM, Kowal MH, Maher BS, Cooper ME, Marazita ML. 2001. Case/control family study of autonomic nervous system dysfunction in idiopathic congenital central hypoventilation syndrome. Am J Med Genet 100:237-245.
151. Weese-Mayer DE, Berry-Kravis EM, Maher BS, Silvestri JM, Curran ME, Marazita ML. 2003a. Sudden infant death syndrome: Association with a promoter
152. Weese-Mayer DE, Zhou L, Berry-Kravis EM, Maher BS, Silvestri JM, Marazita ML. 2003b. Association of the serotonin transporter gene with sudden infant death syndrome: A haplotype analysis. Am J Med Genet Part A 122A:238-245.
153. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Silvestri JM, Curran ME, Marazita ML. 2003c. Idiopathic congenital central hypoventilation syndrome: Analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2B. Am J Med Genet Part A 123A:267-278.
154. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Curran ME, Silvestri JM, Marazita ML. 2004. Sudden infant death syndrome: Case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development. Pediatr Res 56:391-395.
155. Wilde AA, Jongbloed RJ, Doevendans PA, Duren DR, Hauer RN, van Langen IM. van Tintelen JP, Smeets HJ, Meyer H, Geelen JL. 1999. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol 33:327-332.
156. Zhou FC, Sari Y, Zhang JK. 2000. Expression of serotonin transporter protein in developing rat brain. Brain Res Dev Brain Res 119:33-45.